logo

Viveve Medical Inc. (VIVE)



Trade VIVE now with
  Date
  Headline
1/16/2019 8:30:32 AM Viveve Medical Reports $18.5 Mln In Preliminary 2018 Revenue
1/3/2019 8:28:40 AM Viveve Medical Completes Enrollment In LIBERATE-International Trial
12/6/2018 4:12:45 PM Viveve Announces Proposed Public Offering Of Shares Of Common Stock
9/13/2018 8:29:04 AM Viveve Medical Adds Steve Basta And Karen Zaderej To Board
8/7/2018 8:29:02 AM Viveve Announces FDA Approval To Continue VIVEVE II Clinical Study
7/10/2018 8:29:03 AM Viveve Medical Reiterates 2018 Revenue Guidance Of $22 Mln -$24 Mln
7/3/2018 8:28:26 AM Viveve Submits VIVEVE II Clinical Study 30-Day Patient Safety Data To FDA
6/4/2018 8:29:59 AM Viveve Announces Settlement Of Patent Infringement Litigation With Thermi
5/16/2018 8:25:14 AM Viveve Announces Initiation Of VIVEVE II Clinical Study
5/10/2018 4:23:42 PM Viveve Medical Q1 Loss/share $0.49 Vs. Loss $0.57 Year Ago
5/10/2018 2:10:34 PM Viveve Appoints Scott Durbin As CEO
3/19/2018 8:28:26 AM Viveve Announces FDA Approval Of IDE To Conduct VIVEVE II Clinical Study
3/15/2018 4:07:47 PM Viveve Medical Q4 Loss/share $0.53 Vs. Loss $0.55 Year Ago
  
 
>